EUVIMEDEUVIMED entdecken
EditorialKommentar

An Unexpected Partnership: Histone Deacetylase 6 and Glutaminase Inhibition Provide an Opportunity to Overcome Resistance in KRAS and LKB1 Co-mutant Lung Tumors

Brandon Nadres, Milica Momcilovic, David B Shackelford, Aaron Lisberg

Journal of Thoracic Oncology · 2023

DOI: 10.1016/j.jtho.2023.04.012 ↗

Kurz gefasst

Editorial in der Zeitschrift Journal of Thoracic Oncology, 2023. Verfasst von Brandon Nadres und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los …. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: NIH, LUNGevity Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsCarcinoma, Non-Small-Cell LungHumansProto-Oncogene Proteins p21(ras)GlutaminaseHistone Deacetylase 6MutationCell Line, Tumor

Substanzen

Proto-Oncogene Proteins p21(ras)GlutaminaseHistone Deacetylase 6KRAS protein, human

Autor:innen und Institutionen

  • Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
  • Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California; Jonsson Comprehensive Cancer Center, David Geffen…
  • Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California; Department of Hematology and Oncology, David Geffen School of Medicine, University of…

Förderung

  • NIH
  • LUNGevity Foundation

Zitieren

APA

Nadres, B., Momcilovic, M., Shackelford, D. B., & Lisberg, A. (2023). An Unexpected Partnership: Histone Deacetylase 6 and Glutaminase Inhibition Provide an Opportunity to Overcome Resistance in KRAS and LKB1 Co-mutant Lung Tumors. Journal of Thoracic Oncology. https://doi.org/10.1016/j.jtho.2023.04.012

Vancouver

Nadres B, Momcilovic M, Shackelford DB, Lisberg A. An Unexpected Partnership: Histone Deacetylase 6 and Glutaminase Inhibition Provide an Opportunity to Overcome Resistance in KRAS and LKB1 Co-mutant Lung Tumors. Journal of Thoracic Oncology. 2023. doi:10.1016/j.jtho.2023.04.012

BibTeX
@article{Nadres2023,
  author = {Nadres, Brandon and Momcilovic, Milica and Shackelford, David B and Lisberg, Aaron},
  title = {An Unexpected Partnership: Histone Deacetylase 6 and Glutaminase Inhibition Provide an Opportunity to Overcome Resistance in KRAS and LKB1 Co-mutant Lung Tumors},
  journal = {Journal of Thoracic Oncology},
  year = {2023},
  doi = {10.1016/j.jtho.2023.04.012}
}
Kostenlos starten →